Detalles de la búsqueda
1.
Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia.
Ann Hematol
; 103(6): 1919-1929, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38630133
2.
Immortalised chronic myeloid leukemia (CML) derived mesenchymal stromal cells (MSCs) line retains the immunomodulatory and chemoprotective properties of CML patient-derived MSCs.
Cell Signal
; 116: 111067, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38281615
3.
Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines.
Leuk Res
; 128: 107054, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36906941
4.
Modulating retinoid-X-receptor alpha (RXRA) expression sensitizes chronic myeloid leukemia cells to imatinib in vitro and reduces disease burden in vivo.
Front Pharmacol
; 14: 1187066, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37324449
5.
Plasma imatinib levels and ABCB1 polymorphism influences early molecular response and failure-free survival in newly diagnosed chronic phase CML patients.
Sci Rep
; 10(1): 20640, 2020 11 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33244077
6.
Prognostic plasma biomarkers of early complications and graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation.
EJHaem
; 1(1): 219-229, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32885223
7.
Corrigendum to "Chemotherapeutic drugs elicit stemness and metabolic alteration to mediate acquired drug-resistant phenotype in acute myeloid leukemia cell lines" [Leukemia Res. 128, 107054].
Leuk Res
; 130: 107329, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37258357
8.
Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2.
PLoS One
; 12(5): e0177227, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28505160
Resultados
1 -
8
de 8
1
Próxima >
>>